UAE doctors turn to AI to explain why cancer treatments work for some but not others
Cancer specialists in the UAE are using artificial intelligence to understand more about why treatment works for some but fails to help others. Two patients can have the same type and stage of cancer, and receive the same treatment, but experience markedly different outcomes. Dubai-based Nexomic, which has been established in part by one of the UAE’s leading oncologists, aims to harness…
Dubai-based Nexomic, spearheaded by a leading UAE oncologist, is harnessing artificial intelligence to delve deeper into the complexities of cancer treatment outcomes. Two patients with identical cancer types and stages may respond differently to the same therapy, a phenomenon that prompted the development of Nexomic's AI platform, DeepOmic.
This multi-omics system integrates various layers of tumour biology, including gene activity, DNA alterations, and other molecular data. The ultimate goal is to provide oncologists with comprehensive insights into a tumor's behavior and its response to treatment. Dr. Ghadeer Ghosheh, Nexomic's Chief AI Officer, explains that cancer is not a single data point, but a complex biological system, and by combining these layers of information, doctors hope to translate deeper molecular patterns into clinically useful knowledge.
The AI-driven approach promises to move beyond identifying individual genetic mutations to understanding broader biological patterns. Successful implementation depends on robust data access, which Nexomic has secured through a data-sharing agreement with Genomics England and Cancer Research Horizons. This collaboration aims to validate the platform's effectiveness across diverse datasets, ultimately paving the way for more personalized and effective cancer treatments.
Written by urgent.news from The National UAE's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
